{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T01:46:30Z","timestamp":1783734390286,"version":"3.55.0"},"reference-count":13,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Facial Plastic Surgery &amp; Aesthetic Medicine"],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To evaluate trends in botulinum toxin (BTX) industry payments to physicians.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Cross-sectional analysis of nonroyalty, BTX-specific payments made by Allergan (Botox), Ipsen (Dysport), and Merz (Xeomin) to physicians using the 2016\u20132020 Open Payments Database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Between 2016 and 2020, &gt;$27 million in payments was made for BTX-related activities to dermatologists, neurologists, ophthalmologists, otolaryngologists, and plastic surgeons, with payments ranging from $3.9 million in 2016 to $8.7 million in 2019. 21.7% was paid to dermatologists, 57.5% to neurologists, 5.9% to ophthalmologists, 5.7% to otolaryngologists, and 9.1% to plastic surgeons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Growing amounts are being paid to physicians for BTX-related activities\u2014both medical and aesthetic. Despite the variety of indications for BTX within otolaryngology, otolaryngology payments were overshadowed by other specialties, which may reflect greater BTX utilization in those specialties.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/fpsam.2023.0198","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T09:29:20Z","timestamp":1711445360000},"page":"512-516","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Trends in Botulinum Toxin-Related Industry Payments to Physicians"],"prefix":"10.1177","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1964-7109","authenticated-orcid":false,"given":"Sina J.","family":"Torabi","sequence":"first","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, University of California, Irvine, Orange, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0754-3115","authenticated-orcid":false,"given":"Milind","family":"Vasudev","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, University of California, Irvine, Orange, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Lonergan","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, University of California, Irvine, Orange, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy I.","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, University of California, Irvine, Orange, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam P.","family":"Dalwadi","sequence":"additional","affiliation":[{"name":"Loyola University Stritch School of Medicine, Maywood, Illinois, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.F.","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, University of California, Irvine, Orange, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.","family":"Kuan","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, University of California, Irvine, Orange, California, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"e_1_3_4_2_2","unstructured":"Insights FB. Botulinum Toxin Market Size Share & Industry Analysis By Application (Therapeutic and Aesthetic) By Type (Botulinum Toxin Type A and Botulinum Toxin Type B) By End User (Specialty & Dermatology Clinics Hospitals & Clinics and Others) and Regional Forecast 2021\u20132028. https:\/\/www.fortunebusinessinsights.com\/industry-reports\/botulinum-toxin-market-100996 Accessed: May 1 2023."},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/head.14040"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1303523"},{"key":"e_1_3_4_5_2","unstructured":"Services CfMM. Open Payments Data. https:\/\/www.cms.gov\/openpayments\/data#:~:text=Open%20Payments%20Program%20Year%202021&text=*Ownership%20or%20Investment%20Interest%20includes or%20teaching%20hospital%20covered%20recipients Accessed: May 1 2023."},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/0194599815573718"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/lary.29746"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2010.01678.x"},{"issue":"3","key":"e_1_3_4_9_2","first-page":"190","article-title":"Kaplan Award 1998","volume":"39","author":"Castillo J","year":"1999","unstructured":"Castillo J, , Mu\u00f1oz P, , Guitera V, , Pascual J. Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache. 1999; 39(3):190\u2013196. doi:10.1046\/j.1526-4610.1999.3903190.x","journal-title":"Epidemiology of chronic daily headache in the general population. Headache"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1998.3807497.x"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3959(02)00348-2"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-021-02483-1"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13090"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.6188"}],"container-title":["Facial Plastic Surgery &amp; Aesthetic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/fpsam.2023.0198","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/fpsam.2023.0198","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/fpsam.2023.0198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T21:10:32Z","timestamp":1781557832000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/fpsam.2023.0198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9,1]]}},"alternative-id":["10.1089\/fpsam.2023.0198"],"URL":"https:\/\/doi.org\/10.1089\/fpsam.2023.0198","relation":{},"ISSN":["2689-3614","2689-3622"],"issn-type":[{"value":"2689-3614","type":"print"},{"value":"2689-3622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]}}}